WASHINGTON – Former Advamed CEO Stephen Ubl discussed the need to create a sound regulatory and reimbursement environment for personalized medications in his new role as the head of the Pharmaceutical Research and Manufacturers of America (PhRMA), during a keynote at last week’s conference sponsored by the Personalized Medicine Coalition.